Feed / OLMA

Olema Pharmaceuticals, Inc.

OLMA

Healthcare · 11.29 -4.8% today

Participation confirmed · construction unavailableMarket checked 19 Aug, 15:55 GMT-4

Jodie situation report

Olema Pharmaceuticals, Inc.'s move is being confirmed by its market group.

No new filing conclusion is available. 8 of 15 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.

Company-4.8% todayVolume comparison unavailable
Market group8 of 15 activeBiopharmaceuticals and Care · inactive
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 10 of 15 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ABBV begins moving with the group.

Invalidation: The live read weakens if participation falls to 5 of 15 members or fewer.

Watch this read

Who this business touches

The relationships behind OLMA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

NVSNovartis AGpartnerMay 12, 2026

The execution of OPERA-02 is supported by our clinical trial collaboration and supply agreement with Novartis Pharma AG (Novartis), which was also announced in December 2024.

PFEPfizer, Inc.partnerMay 12, 2026

We have established clinical collaborations with both Novartis and Pfizer and we intend to continue evaluating opportunities to work with partners that meaningfully enhance our capabilities with respect to the development and commercialization of our product…

ARVNArvinas, Inc.competitorMar 16, 2026

There are several currently marketed drugs and product candidates currently in development for the treatment of ER+ breast cancer that target the estrogen receptor that may compete with palazestrant including: fulvestrant, marketed as Faslodex® by AstraZeneca…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

OLMA is currently a Participant in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.